Pieris Pharmaceuticals, Inc.
Palvella Therapeutics develops topical therapies using its QTORIN platform for rare skin diseases and vascular malformations.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 13Latest story
Palvella Therapeutics develops topical therapies using its QTORIN platform for rare skin diseases and vascular malformations.
November 2026
October 2026
August 2026
June 2026